Explore Janssen’s innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.
Company Overview. As of December 26, 1996 Ortho-McNeil Pharmaceutical, LLC was acquired by Janssen Pharmaceuticals, Inc. Ortho-McNeil Pharmaceutical, LLC develops and provides prescription drugs ...
The company was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases. Ortho-McNeil and Janssen Pharmaceutica together compose the Ortho-McNeil-Janssen group within Johnson ...
In Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., No. 07-1223 (Fed. Cir. Mar. 31, 2008), the Federal Circuit held that the district court correctly construed the claim term “and” in U.S. Patent No. 4,513,006 (“the ’006 patent”) owned by Ortho-McNeil Pharmaceutical, Inc. (“Ortho-McNeil”); affirmed its dismissal of Mylan Laboratories, Inc. and Mylan Pharmaceuticals ...
The ’407 patent, assigned to Daiichi Sankyo Co. (“Daiichi”) and exclusively licensed to Ortho−McNeil Pharmaceutical, Inc. and Ortho−McNeil, Inc. (collectively “Ortho”), claims levofloxacin. Levofloxacin is the levorotatory enantiomer of the racemate ofloxacin, an antimicrobial drug previously approved by the FDA.
Ortho-McNeil scientist Dr. Bruce Maryanoff invented this pharmaceutical during a search for new antidiabetic drugs. Topiramate is a reaction intermediate in the synthesis Dr. Maryanoff ran as part of his antidiabetic efforts.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. is headquartered in Titusville, New Jersey. About Janssen Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, New Jersey, and is the only large pharmaceutical company in the United States dedicated solely to mental health.
ORTHO-McNEIL PHARMACEUTICAL, INC.: PARAFON FORTE DSC chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of...
This matter comes before the Court on the motion by Plaintiff Ortho-McNeil Pharmaceutical, Inc. ("Ortho") for partial summary judgment, pursuant to FED. R. CIV. P. 56, on the § 112 invalidity defenses of Defendants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. (collectively "Mylan").